SAB Biotherapeutics reported total assets of $235.64M and total liabilities of $24.72M for the quarter ended Sep 2026, up 28.5% year over year. This balance sheet covers 24 quarters of results from Dec 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 | Sep2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 33.21M | 22.41M | 16.62M | 8.33M | 15.05M | 13.06M | 7.77M | 2.43M | 56.57M | 14.03M | 17.24M | 9.20M | 8.90M | 5.64M | 3.69M | 29.42M | 10.50M | 20.52M | 8.27M | 14.44M | ||||
| Short-term InvestmentsInvestments (Current) | 30.02M | 20.08M | 21.23M | 11.86M | 7.21M | 2.02M | 81.46M | 86.09M | 86.87M | 94.37M | 89.61M | |||||||||||||
| Cash & Current Investments | 33.21M | 22.41M | 16.62M | 8.33M | 15.05M | 13.06M | 7.77M | 2.43M | 56.57M | 44.06M | 37.33M | 30.43M | 20.76M | 12.85M | 5.71M | 110.88M | 96.59M | 107.39M | 102.63M | 104.05M | ||||
| Receivables - NetNet Receivables | 8.01M | 11.79M | 9.61M | 12.94M | 5.56M | 0.76M | 0.36M | |||||||||||||||||
| Receivables | 8.01M | 11.79M | 9.61M | 12.94M | 5.56M | 0.76M | 0.36M | |||||||||||||||||
| Prepaid Assets | 2.64M | 2.99M | 1.77M | 0.91M | 1.49M | 1.21M | 0.87M | 0.70M | 2.34M | 2.70M | 2.03M | 2.04M | 2.98M | 3.42M | 3.59M | 1.84M | 3.51M | 3.84M | 3.46M | 2.19M | ||||
| Current Assets | 50.19M | 37.18M | 28.00M | 22.18M | 22.10M | 15.03M | 9.01M | 3.13M | 58.91M | 46.95M | 39.58M | 32.54M | 23.79M | 16.30M | 9.31M | 113.28M | 101.05M | 112.78M | 107.94M | 107.74M | ||||
| Non-Current Assets | ||||||||||||||||||||||||
| Construction in Progress | 4.61M | 0.31M | 0.33M | 0.05M | 0.02M | 0.02M | 759.00 | 1.44M | 411.00 | 0.00M | ||||||||||||||
| Land & Improvements | 576.00 | 576.00 | ||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 24.31M | 24.97M | 24.84M | 24.03M | 23.25M | 22.37M | 21.53M | 20.62M | 19.74M | 17.90M | 16.92M | 16.08M | 15.37M | 14.61M | 13.86M | 13.11M | 13.31M | 13.81M | 14.23M | 15.65M | ||||
| Long-Term Investments | 1.24M | 50.61M | 46.89M | 110.24M | 105.35M | 101.29M | ||||||||||||||||||
| Other Non-Current Assets | 13.10M | 0.54M | 0.50M | 0.47M | 0.43M | 0.43M | 0.37M | 0.35M | 0.32M | 0.29M | 0.25M | 0.22M | 0.19M | 156.38M | 124.07M | 5.31M | 5.28M | 5.34M | 5.81M | |||||
| Non-Current Assets | 30.95M | 31.30M | 31.40M | 30.33M | 28.81M | 27.64M | 26.44M | 25.21M | 25.03M | 24.42M | 22.31M | 21.26M | 20.40M | 21.82M | 20.82M | 70.17M | 71.76M | 135.69M | 130.27M | 127.91M | ||||
| Assets | 81.14M | 68.49M | 59.41M | 52.51M | 50.90M | 42.67M | 35.44M | 28.34M | 83.94M | 71.37M | 61.89M | 53.80M | 44.20M | 38.12M | 30.13M | 183.45M | 172.81M | 248.47M | 238.21M | 235.64M | ||||
| Liabilities | ||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||
| Accounts Payables | 12.46M | 11.86M | 9.86M | 10.24M | 9.92M | 8.19M | 5.93M | 5.30M | 6.69M | 5.17M | 5.05M | 6.88M | 5.47M | 6.06M | 7.09M | 6.85M | 6.58M | 5.39M | 7.21M | 11.81M | ||||
| Notes Payables | 1.80M | 1.04M | 0.28M | 0.03M | 0.77M | 0.44M | 0.11M | 0.54M | 1.05M | 0.84M | 0.62M | 0.28M | 0.14M | |||||||||||
| Payables | 14.25M | 12.90M | 10.14M | 10.26M | 10.69M | 8.63M | 6.04M | 5.84M | 7.74M | 6.01M | 5.67M | 6.88M | 5.75M | 6.19M | 7.09M | 6.85M | 6.58M | 5.39M | 7.21M | 11.81M | ||||
| Accumulated Expenses | -0.60M | -2.60M | -2.22M | 0.01M | 0.02M | 0.06M | 0.07M | 0.08M | 0.09M | 0.10M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | ||||||
| Other Accumulated Expenses | 0.28M | 0.34M | 0.34M | 0.25M | 0.51M | 0.20M | 0.27M | 0.21M | 0.48M | 0.64M | 0.22M | 1.70M | 0.52M | 0.74M | 0.81M | 1.62M | 1.23M | 1.01M | 1.61M | 5.07M | ||||
| Current Leases | 0.16M | 0.15M | 0.14M | 0.14M | 0.13M | 0.13M | 0.13M | 0.13M | 0.13M | 0.13M | 0.14M | 0.14M | 0.14M | 0.15M | 0.15M | 0.15M | 0.15M | 0.16M | 0.16M | 0.16M | ||||
| Current Taxes | 24.68M | 0.09M | ||||||||||||||||||||||
| Current Deferred Revenue | 0.10M | -0.10M | -0.10M | -0.10M | 2.94M | 2.89M | 1.63M | 1.32M | 0.38M | 0.11M | 0.11M | |||||||||||||
| Total Current Liabilities | 26.46M | 19.27M | 16.39M | 17.10M | 14.99M | 13.67M | 11.01M | 9.21M | 10.81M | 8.30M | 7.55M | 8.82M | 7.98M | 9.65M | 10.68M | 10.79M | 10.68M | 9.85M | 11.71M | 14.80M | ||||
| Non-Current Liabilities | ||||||||||||||||||||||||
| Capital Leases | 3.76M | 3.73M | 3.69M | 3.66M | 3.63M | 3.60M | 3.49M | 3.45M | 3.42M | 3.38M | 3.35M | 3.31M | 3.28M | 3.24M | 3.20M | 3.16M | 3.12M | 3.08M | 3.04M | 3.00M | ||||
| Non-Current Debt | 1.80M | 0.54M | ||||||||||||||||||||||
| Convertible Debt | 41.26M | 37.12M | 0.54M | 0.54M | 0.54M | |||||||||||||||||||
| Non-Current Deferred Revenue | ||||||||||||||||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||
| Operating Leases | 1.65M | 1.36M | 1.06M | 0.76M | 0.36M | 0.23M | 0.09M | 0.64M | 0.55M | 0.78M | 0.68M | 0.58M | 2.47M | 2.26M | 2.04M | 1.88M | 2.17M | 1.45M | 1.35M | |||||
| Other Non-Current Liabilities | 10.72M | 2.87M | 1.14M | 0.36M | 0.32M | 0.24M | 0.60M | 0.42M | 11.77M | 6.31M | 4.09M | 4.08M | 6.39M | 1.35M | 1.98M | 2.38M | 5.64M | 6.12M | 7.23M | 5.58M | ||||
| Total Non-Current Liabilities | 31.87M | 24.36M | 21.15M | 21.53M | 19.53M | 18.03M | 15.13M | 12.66M | 14.87M | 12.24M | 11.68M | 12.81M | 11.84M | 15.36M | 16.13M | 15.99M | 15.68M | 15.10M | 16.20M | 19.15M | ||||
| Total Liabilities | 42.59M | 27.23M | 22.29M | 21.88M | 19.85M | 18.27M | 15.73M | 13.08M | 26.64M | 18.55M | 15.77M | 16.89M | 18.23M | 16.71M | 18.11M | 18.37M | 21.32M | 21.22M | 23.43M | 24.72M | ||||
| Shareholder's Equity | ||||||||||||||||||||||||
| Total Debt | 1.80M | 1.04M | 0.28M | 0.03M | 1.31M | 0.44M | 0.11M | 0.54M | 1.05M | 0.84M | 0.62M | 0.28M | 0.14M | |||||||||||
| Common Equity | 38.55M | 41.26M | 37.12M | 30.62M | 31.06M | 24.40M | 19.72M | 15.26M | 57.30M | 52.82M | 46.12M | 36.90M | 25.97M | 21.41M | 12.02M | 165.07M | 151.50M | 227.25M | 214.79M | 210.92M | ||||
| Liabilities and Shareholders Equity | 81.14M | 68.49M | 59.41M | 52.51M | 50.90M | 42.67M | 35.44M | 28.34M | 83.94M | 71.37M | 61.89M | 53.80M | 44.20M | 38.12M | 30.13M | 183.45M | 172.81M | 248.47M | 238.21M | 235.64M | ||||
| Treasury Stock | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | 5.52M | |||||
| Retained Earnings | -29.13M | -28.14M | -32.92M | -40.00M | -47.87M | -55.22M | -62.10M | -67.21M | -90.06M | -95.10M | -102.42M | -112.80M | -124.17M | -129.40M | -139.50M | -94.03M | -110.90M | -129.80M | -152.30M | -174.60M | ||||
| Preferred Shares | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 67.00 | 62.00 | |||||||||||||||
| Treasury Shares | 0.55M | 0.55M | 0.55M | 0.05M | 0.55M | 0.55M | 0.55M | -0.05M | -0.05M | -0.05M | -0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M |
Pull SAB Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=SABS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "SABS", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=SABS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();